ClinConnect ClinConnect Logo
Search / Trial NCT03293719

Post-market Follow up Study of the 'BPK-S Integration' UC as Primary Implant in the Variants CoCr or Ceramic

Launched by PETER BREHM GMBH · Sep 21, 2017

Trial Information

Current as of May 03, 2025

Terminated

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Congenital or acquired knee joint defects/deformation
  • Defects or malfunction of the knee joint
  • Arthrosis (degenerative, rheumatic)
  • Post-traumatic arthritis
  • Symptomatic knee instability
  • Reconstruction of flexibility
  • Patients with metal hypersensitivity (ceramic tibia/femur)
  • Exclusion Criteria:
  • Illnesses which can be treated without using a knee joint implant.
  • Acute or chronic infections near the implantation
  • Systemic diseases and metabolic disorders
  • Serious osteoporosis
  • Serious damage to the bone structures that impedes stable implantation of the implant components
  • Diseases that impair bone growth, e.g. cancer, renal dialysis, osteopenia, etc.
  • Bone tumors in the area of the implant anchoring
  • Obesity or overweight of the patient
  • Overload of the knee implant to be expected
  • Abuse of medication, drug abuse, alcoholism or mental disease
  • Pregnancy
  • Lack of patient cooperation
  • Sensitivity to foreign matter in the implant materials
  • Patients under the age of 18
  • Patients participating in another trial

About Peter Brehm Gmbh

Peter Brehm GmbH is a renowned medical technology company specializing in the development and manufacturing of innovative orthopedic implants and surgical instruments. With a commitment to enhancing patient outcomes through advanced engineering and research, the company actively participates in clinical trials to evaluate the safety and efficacy of its products. Leveraging a robust portfolio of solutions, Peter Brehm GmbH collaborates with healthcare professionals and institutions worldwide to drive forward the field of orthopedic surgery and improve the quality of life for patients.

Locations

Vienna, Oberösterreich, Austria

Patients applied

0 patients applied

Trial Officials

Christian E. Berger, Prof.

Principal Investigator

Sozialmedizinisches Zentrum Ost - Donauspital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials